Neoplasms

Respiratory Tract (Lung and Bronchial) Diseases

All Conditions

Skin and Connective Tissue Diseases

Lung Neoplasms

Carcinoma, Non-Small-Cell Lung

Melanoma

Antineoplastic Agents

All Drugs and Chemicals

Nivolumab

Antineoplastic Agents, Immunological

Immune Checkpoint Inhibitors

DF6002

Sean Rossi

Jennifer Valerin, MD

Mario Sznol, MD

Jose Lutzky, MD

Sharad Ghamande, MD

Mohammed Milhem, MD

Elizabeth Buchbinder, MD

Dipesh Uprety, MD

Raghad Abdul-Karim, MD

Arkadiusz Dudek, MD

Eric Whitman, Site 0004

Jinyu Lu, MD

Christos Fountzilas, MD

Jorge Garcia, MD

Raid Aljumaily, MD

Benedito Carneiro, MD

Meredith McKean, MD

Hussein Tawbi, MD

Sangeeta Goswami, Site 0009

Siwen Hu-Lieskovan, MD

Alexander Spira, Site 0015

Ariel Nelson, MD

Site 0026

Site 0002

Site 0027

Site 0001

Site 0029

Site 0031

Site 0030

Site 0028

Site 0025

Jean-Marie Cuillerot, MD

The purpose of this study is to evaluate the safety, tolerability, drug-levels, drug-effects and preliminary anti-tumor activity of DF6002 alone and in combination with Nivolumab in participants with advanced solid tumors.

A Study of DF6002 Alone and in Combination With Nivolumab

A Phase 1/2, First-In-Human, Multi-Part, Open-Label, Multiple-Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, Biological, and Clinical Activity of DF6002 as a Monotherapy and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors, and Expansion in Selected Indications

Dragonfly Therapeutics

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
A Study of DF6002 Alone and in Combination With Nivolumab	NCT04423029	Solid Tumors	DF6002 Nivolumab	18 Years -	Dragonfly Therapeutics
A Study of DF6002 Alone and in Combination With Nivolumab	NCT04423029	Solid Tumors	DF6002 Nivolumab	18 Years -	Dragonfly Therapeutics

Spots Global Cancer Trial Database for df6002

Every month we try and update this database with for df6002 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Spots Global Cancer Trial Database for df6002

Every month we try and update this database with for df6002 cancer trials from around the world to help patients and their families find trials that might be right for them. We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Every month we try and update this database with for df6002 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.